A new trial will explore if a special medical tampon can help detect the earliest signs of ovarian cancer. The test uses the ...

A new trial is testing whether a specialist medical tampon could help improve the early diagnosis of ovarian cancer. The ...

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study ...

Currently more than 50 per cent of women are diagnosed with ovarian cancer at an advanced stage when fewer treatment options ...

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...

If you have recurrent or platinum-resistant ovarian cancer, your doctor may recommend folate receptor alpha (FRα) testing. If you test positive for elevated levels of FRα (expressed on 75 percent or ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

Women with an inherited risk of developing ovarian cancer because they have the so-called Angelina Jolie gene alteration can now be tested on the NHS thanks to UCL research. University College London ...

Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor ...